NCT03243656View on ClinicalTrials.gov

Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

December 29, 2019

Study Completion Date

January 5, 2020

Conditions
Eltrombopag
Interventions
DRUG

Eltrombopag

An oral thrombopoietin receptor agonist

Trial Locations (1)

71511

Facility of medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03243656 - Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia | Biotech Hunter | Biotech Hunter